| Literature DB >> 25960033 |
Tetsushi Hirano1, Shogo Yanai, Takuya Omotehara, Rie Hashimoto, Yuria Umemura, Naoto Kubota, Kiichi Minami, Daichi Nagahara, Eiko Matsuo, Yoshiko Aihara, Ryota Shinohara, Tomoyuki Furuyashiki, Youhei Mantani, Toshifumi Yokoyama, Hiroshi Kitagawa, Nobuhiko Hoshi.
Abstract
Neonicotinoids, some of the most widely used pesticides in the world, act as agonists to the nicotinic acetylcholine receptors (nAChRs) of insects, resulting in death from abnormal excitability. Neonicotinoids unexpectedly became a major topic as a compelling cause of honeybee colony collapse disorder, which is damaging crop production that requires pollination worldwide. Mammal nAChRs appear to have a certain affinity for neonicotinoids with lower levels than those of insects; there is thus rising concern about unpredictable adverse effects of neonicotinoids on vertebrates. We hypothesized that the effects of neonicotinoids would be enhanced under a chronic stressed condition, which is known to alter the expression of targets of neonicotinoids, i.e., neuronal nAChRs. We performed immunohistochemical and behavioral analyses in male mice actively administered a neonicotinoid, clothianidin (CTD; 0, 10, 50 and 250 mg/kg/day), for 4 weeks under an unpredictable chronic stress procedure. Vacuolated seminiferous epithelia and a decrease in the immunoreactivity of the antioxidant enzyme glutathione peroxidase 4 were observed in the testes of the CTD+stress mice. In an open field test, although the locomotor activities were not affected, the anxiety-like behaviors of the mice were elevated by both CTD and stress. The present study demonstrates that the behavioral and reproductive effects of CTD become more serious in combination with environmental stress, which may reflect our actual situation of multiple exposure.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25960033 PMCID: PMC4638285 DOI: 10.1292/jvms.15-0188
Source DB: PubMed Journal: J Vet Med Sci ISSN: 0916-7250 Impact factor: 1.267
Fig. 1.Effects of combined exposure on the daily gel intake (A), body weights (B) and testis weights (C) in the non-stressed (open column) and stressed groups (closed column). The two-way ANOVA showed significant main effects for the CTD and stress (P<0.01), but the interaction effects were not significant in gel intake and body weights. (A) CTD dose-dependently inhibited the gel intake, and the inhibition was significant in all CTD-administration groups compared to the CTD-0 groups. The stress procedure significantly inhibited the gel intake in each CTD-administration group. (B) The body weights of the CTD-250 stress and non-stressed groups were significantly lower than those of the other dose groups, in addition to the significant difference between the CTD-0 and CTD-10 groups. The post hoc analyses also revealed that there were significant differences between the CTD-0 and CTD-250 stress and non-stressed groups. (C) The two-way ANOVA showed a significant main effect for stress (P<0.01), but the interaction effect was not significant in the absolute weights of testes. The stress procedure significantly suppressed the absolute testes weights in all stress groups, except the CTD-10 group. Values are mean ± SD (n=5 mice each). *P<0.05, **P<0.01.
Body weight, gel intake, putative CTD exposure and testis weights
| Groups | ||||||||
|---|---|---|---|---|---|---|---|---|
| CTD-0 | CTD-0 + Stress | CTD-10 | CTD-10 + Stress | CTD-50 | CTD-50 + Stress | CTD-250 | CTD-250 + Stress | |
| Body weight (g) | 28.62 ± 1.66 | 26.48 ± 0.72 | 26.98 ± 0.99 | 25.36 ± 1.22 | 27.50 ± 0.82 | 25.24 ± 0.78 | 25.82 ± 0.99 | 23.76 ± 0.40 |
| Gel intake / day (g) | 6.13 ± 1.37 | 5.64 ± 2.80 | 4.41 ± 0.84 | 2.85 ± 1.77 | 4.60 ± 1.59 | 3.55 ± 2.09 | 3.64 ± 0.64 | 2.38 ± 1.42 |
| [ 6.66 ± 2.56 ] | [ 3.73 ± 1.59 ] | [ 4.65 ± 1.79 ] | [ 3.16 ± 1.09 ] | |||||
| Putative exposure (mg/kg/day) | 0 | 0 | 8.82 ± 1.68 | 5.70 ± 3.54 | 46.0 ± 15.9 | 35.5 ± 20.9 | 182 ± 32 | 119 ± 71 |
| [ 7.46 ± 3.18 ] | [ 46.5 ± 17.9 ] | [ 158 ± 54.5 ] | ||||||
| Testis weight (mg) | 99.6 ± 5.5 | 88.2 ± 11.8 | 95.7 ± 9.6 | 90.5 ± 9.7 | 100.3 ± 9.8 | 81.1 ± 8.2 | 97.5 ± 7.8 | 87.5 ± 9.7 |
Values are the mean ± SD (n=5 mice each). The values in square brackets are the averages after the removal of values in the deprivation days from the calculation.
Fig. 2.Behavioral effect of combined exposure of CTD and stress in the open field activity in the non-stressed and stressed groups. (A) A representative trajectory map of the mice as illustrated by the video tracking software. The exploratory behaviors in the center zone (30 × 30 cm) of the open field (60 × 60 cm) were dose-dependently suppressed by CTD compared to the non-administration groups. (B) Total distances traveled in the open field of the non-stressed (open columns) and stressed groups (closed columns). No marked difference was detected by two-way ANOVA in the total distances traveled. (C) Time spent in the center zone in the open field of the non-stressed (open columns) and stressed groups (closed columns). Two-way ANOVA showed significant main effects for CTD (P<0.05) and stress (P<0.01), but the interaction effect was not significant. CTD significantly inhibited the times spent in the center zone in the CTD-250 groups compared to the non-CTD administration groups. A significant anxiogenic effect of the stress procedure was observed between the CTD-0 groups. In the non-stressed condition, there were significant differences in the CTD-10 and CTD-50 groups compared to the CTD-0 group. Values are mean ± SD (n=5 mice each). *P<0.05, **P<0.01.
Fig. 3.Representative histology of the testis in the non-stressed and stressed groups. The seminiferous tubules of the control group showed robust spermatogenesis with densely stacked germ cells. Multinucleated giant cells (arrow) were occasionally observed in the testes of the CTD-0+stress groups. In the CTD groups, dose-dependent vacuoled degeneration (arrowhead) of seminiferous tubules was observed. Degenerated seminiferous tubules only composed of Sertoli cells were present in the CTD-250 groups. Bar=100 µm.
Fig. 4.Representative immunohistochemistry for GPx4 of the testis in the non-stressed and stressed groups. GPx4 immunoreactivities were detected in sperms and spermatids in the testes of the control group. In the testes of the stressed groups, reduced immunoreactivity of GPx4 in sperm was observed. In the CTD groups, spermatids showed weakened immunoreactivity of GPx4. Sertoli cells ectopically expressed GPx4 in degenerated seminiferous tubules of the CTD-50+stress group and the CTD-250 groups. Bar=100 µm.